The/DT
use/NN
of/IN
interferon-gamma-treated/JJ
U937/NN
cells/NNS
in/IN
chemiluminescence/NN
assays/NNS
to/TO
detect/VB
red/JJ
cell/NN
,/,
platelet/NN
and/CC
granulocyte/NN
antibodies/NNS
of/IN
potential/JJ
clinical/JJ
significance/NN
./.

The/DT
chemiluminescent/JJ
(/(
CL/JJ
)/)
response/NN
of/IN
interferon-gamma-treated/JJ
U937/NN
(/(
IFN-U937/NN
)/)
cells/NNS
to/TO
sensitized/VBN
target/NN
cells/NNS
has/VBZ
been/VBN
used/VBN
to/TO
detect/VB
red/JJ
cell/NN
,/,
platelet/NN
and/CC
granulocyte/NN
antibodies/NNS
./.
=====
A/DT
clone/NN
of/IN
U937/NN
cells/NNS
was/VBD
selected/VBN
which/WDT
expressed/VBD
Fc/NN
receptor/NN
I/NN
(/(
Fc/NN
gamma/NN
RI/NN
)/)
and/CC
which/WDT
,/,
after/IN
incubation/NN
with/IN
IFN-gamma/NN
for/IN
72/CD
h/NN
,/,
was/VBD
capable/JJ
of/IN
generating/VBG
high/JJ
levels/NNS
of/IN
lucigenin-enhanced/JJ
CL/NN
./.
=====
The/DT
CL/NN
responses/NNS
of/IN
IFN-U937/NN
cells/NNS
and/CC
peripheral/JJ
blood/NN
human/JJ
monocytes/NNS
to/TO
sensitized/VBN
red/JJ
cells/NNS
,/,
platelets/NNS
or/CC
granulocytes/NNS
were/VBD
then/RB
compared/VBN
./.
=====
Assays/NNS
using/VBG
monocytes/NNS
or/CC
IFN-U937/NN
cells/NNS
were/VBD
of/IN
comparable/JJ
sensitivity/NN
for/IN
detection/NN
of/IN
antibodies/NNS
against/IN
all/DT
three/CD
types/NNS
of/IN
target/NN
cell/NN
./.
=====
In/IN
addition/NN
,/,
the/DT
use/NN
of/IN
IFN-U937/NN
cells/NNS
reduced/VBD
interassay/JJ
variation/NN
and/CC
simplified/VBD|VBN
assay/NN
performance/NN
./.
=====
The/DT
potential/JJ
clinical/JJ
usefulness/NN
of/IN
these/DT
CL/NN
assays/NNS
was/VBD
suggested/VBN
by/IN
the/DT
ability/NN
of/IN
both/CC
monocytes/NNS
and/CC
IFN-U937/NN
cells/NNS
to/TO
respond/VB
to/TO
red/JJ
cells/NNS
,/,
platelets/NNS
or/CC
granulocytes/NNS
sensitized/VBN
with/IN
sera/NN
from/IN
pregnant/JJ
women/NNS
whose/WP$
babies/NNS
had/VBD
either/CC
haemolytic/JJ
disease/NN
of/IN
the/DT
newborn/JJ
(/(
HDN/NN
)/)
,/,
alloimmune/JJ
thrombocytopenia/NN
or/CC
alloimmune/JJ
neutropenia/NN
respectively/RB
./.
=====
In/IN
addition/NN
,/,
monocytes/NNS
and/CC
IFN-U937/NN
cells/NNS
both/DT
responded/VBD
to/TO
red/JJ
cells/NNS
sensitized/VBN
with/IN
antibodies/NNS
against/IN
a/DT
variety/NN
of/IN
specificities/NNS
of/IN
assumed/VBN
(/(
although/IN
not/RB
documented/VBN
)/)
clinical/JJ
significance/NN
for/IN
blood/NN
transfusion/NN
recipients/NNS
./.
=====
In/IN
contrast/NN
,/,
monocytes/NNS
and/CC
IFN-U937/NN
cells/NNS
responded/VBD
only/RB
weakly/RB
to/TO
red/JJ
cells/NNS
sensitized/VBN
with/IN
either/CC
anti-D/JJ
in/IN
sera/NN
from/IN
mothers/NNS
of/IN
babies/NNS
unaffected/JJ
by/IN
HDN/NN
,/,
or/CC
with/IN
antisera/NNS
containing/VBG
high/JJ
titre/NN
antibodies/NNS
with/IN
specificities/NNS
not/RB
normally/RB
associated/VBN
with/IN
significantly/RB
reduced/VBN
red/JJ
cell/NN
survival/NN
./.